The rise in respiratory problems such as asthma and chronic obstructive pulmonary disorder will buoy growth in the $11.7bn inhalation drug delivery device market. While global sales increase of these devices will be modest, some geographic regions will see faster pace growth than others, according to a report by Meddevicetracker.
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
Medtech Insight spoke with Hubert Martens, CEO of Netherlands-based neuromodulation company Salvia Bioelectronics, about the company’s innovative implant for treating chronic migraines, ongoing clinical trials and plans for US clinical trials and commercialization.
Surgify Medical’s selective drill tip, Surgify Halo, is “an obvious choice for surgeons,” said Boris Hofmann, head of ZEISS Ventures and lead investor in the company’s series A funding round.
German Bionic’s new exoskeleton Exia helps healthcare practitioners, nurses, and other caregivers to lift and move patients by supporting muscle movement and reducing the risk of injury.
